SEX DIFFERENCE IN HUMAN GROWTH-HORMONE (GH) RESPONSE TO INTRAVENOUS HUMAN PANCREATIC GH-RELEASING HORMONE ADMINISTRATION IN YOUNG-ADULTS

被引:69
作者
SMALS, AEM [1 ]
PIETERS, GFFM [1 ]
SMALS, AGH [1 ]
BENRAAD, TJ [1 ]
VANLAARHOVEN, J [1 ]
KLOPPENBORG, PWC [1 ]
机构
[1] CATHOLIC UNIV NIJMEGEN, DEPT EXPTL & CHEM ENDOCRINOL, NIJMEGEN, NETHERLANDS
关键词
D O I
10.1210/jcem-62-2-336
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Intravenous administration of a 100-.mu.g dose of human pancreatic GH-releasing hormone (human pancreatic GHRH1-44, indicated by GHRH) disclosed a sex difference in GH responsiveness. The maximum GH increments [41 .+-. 11 (SEM) vs. 15 .+-. 4 ng/ml, P < 0.05] and the areas under the curves (419 .+-. 105 vs. 148 .+-. 53 area U, P < 0.05) were significantly higher in 12 men than in 10 women. No significant correlation was found in either group between the basal plasma estradiol or testosterone levels and the maximum or integrated GH response to GHRH. Serum PRL levels significantly increased in both groups within 5 min after GHRH injection (men, P < 0.001 vs. t = 0; women, P < 0.05 vs. t = 0). The areas under the curves of the PRL responses (355 .+-. 184 vs. 189 .+-. 73 area U) and the maximum PRL increments (58 .+-. 18 vs. 36 .+-. 6 mU/l, P > 0.10) were similar. In conclusion, a sex difference in GH responsiveness to GHRH was found between young adult men and women. Recent in vivo and in vitro data reveal a similar sex difference in rodents and an enhancing effect of androgens, but not estrogens, on the GH response to GHRH. These findings support the theory that in humans testosterone also plays a key role in the genesis of this sex difference.
引用
收藏
页码:336 / 341
页数:6
相关论文
共 29 条
[1]   POTENTIAL USES OF HUMAN PANCREATIC GROWTH HORMONE-RELEASING FACTOR 1-44 AMIDE [J].
BELCHETZ, PE ;
WELDON, SF ;
DAVIS, JC ;
DIVER, MJ ;
SMITH, CS ;
HARRIS, F .
CLINICAL ENDOCRINOLOGY, 1984, 21 (02) :201-208
[2]  
BORGES JLC, 1983, LANCET, V2, P119
[3]  
DAUGHADAY WH, 1974, WILLIAMS TXB ENDOCRI, P53
[4]  
DEBOLD CR, 1984, 7TH INT C END QUEB C
[5]   EFFECTS OF HUMAN PANCREATIC GROWTH HORMONE-RELEASING FACTOR-40 ON SERUM GROWTH-HORMONE, PROLACTIN, LUTEINIZING-HORMONE, FOLLICLE-STIMULATING-HORMONE, AND SOMATOMEDIN-C CONCENTRATIONS IN NORMAL WOMEN THROUGHOUT THE MENSTRUAL-CYCLE [J].
EVANS, WS ;
BORGES, JLC ;
VANCE, ML ;
KAISER, DL ;
ROGOL, AD ;
FURLANETTO, R ;
RIVIER, J ;
VALE, W ;
THORNER, MO .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1984, 59 (05) :1006-1010
[6]  
EVANS WS, 1985, 67TH ANN M END SOC B
[7]   EFFECTS OF ESTROGEN AND SEX DIFFERENCE ON SECRETION OF HUMAN GROWTH HORMONE [J].
FRANTZ, AG ;
RABKIN, MT .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1965, 25 (11) :1470-+
[8]   IDENTIFICATION BY PLAQUE ASSAYS OF A PITUITARY CELL TYPE THAT SECRETES BOTH GROWTH-HORMONE AND PROLACTIN [J].
FRAWLEY, LS ;
BOOCKFOR, FR ;
HOEFFLER, JP .
ENDOCRINOLOGY, 1985, 116 (02) :734-737
[9]   DOSE-RESPONSE RELATIONSHIPS FOR THE EFFECTS OF GROWTH HORMONE-RELEASING FACTOR-(1-44)-NH2 IN YOUNG-ADULT MEN AND WOMEN [J].
GELATO, MC ;
PESCOVITZ, OH ;
CASSORLA, F ;
LORIAUX, DL ;
MERRIAM, GR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1984, 59 (02) :197-201
[10]  
GLICK SN, 1966, RECENT PROG HORM RES, V22, P241